CD4 T cells: Fates, functions, and faults

Blood

Volumn 112, Issue 5, 2008, Pages 1557-1569

  Zhu, Jinfang ^a   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 9; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FATE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; EPIGENETICS; GENE MUTATION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIFFERENTIATION; CLASSIFICATION; CYTOLOGY; GENETIC EPIGENESIS; GENETIC POLYMORPHISM; GENETICS; HISTORY; IMMUNOLOGY; METABOLISM; MOUSE; MUTATION; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; EPIGENESIS, GENETIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 52649167708     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-078154     Document Type: Article

References (179)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA. Coffman RL. Two types of murine helper Tcell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357.
2. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562.
3. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 2006;25: 195-201.
4. Bendelac A, Savage PB. Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297-336.
5. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-173.
6. Paul WE. Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241-251.
7. Weaver CT Harrington LE. Mangan PR. Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory Tcell ties. Immunity. 2006; 24:677-688.
8. Chen Y Kuchroo VK, Inobe J, Hafler DA. Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomy-elitis. Science. 1994;265:1237-1240.
9. Carrier Y, Yuan J, Kuchroo VK. Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol. 2007;178:179-185.
10. Groux H, O'Garra A, Bigler M, et al. ACD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389: 737-742.
11. Jankovic D, Kullberg MC, Feng CG, et al. Conventional T-bet(+)Foxp3(-)Th1 cells are the major source of host-protective regulatory lL-10 during intracellular protozoan infection. J Exp Med. 2007;204:273-283.
12. Anderson CF Oukka M. Kuchroo VJ, Sacks D. CD4(+)CD25(-)Foxp3(-)Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med. 2007;204: 285-297.
13. McGeachy MJ, Bak-Jensen KS, Chen Y et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cellmediated pathology. Nat Immunol. 2007;8:1390-1397.
14. Killar L, MacDonald G. West J, Woods A Bottomly K. Cloned, la-restricted T cells that do not produce interleukin 4(IL4)/B cell stimulatory factor 1 (BSF-1) fail to help antigen-specific B cells. J Immunol. 1987;138:1674-1679.
15. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: lL-2 and lL-4 are required for in vitro generation of lL-4-producing cells. J Exp Med. 1990;172:921-929.
16. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol. 1990;145:3796-3806.
17. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997; 89:587-596.
18. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997;272:21597-21603.
19. Cote-Sierra J, Foucras G, Guo L, etal. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A. 2004;101:3880-3885.
20. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4+ T cells through lL-12 produced by Listeria-induced macrophages. Science. 1993;260:547-549.
21. Szabo SJ, Kim ST. Costa GL, Zhang X. Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:6S5-669.
22. Lighvani AA. Frucht DM, Jankovic D. et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A. 2001;98:15137-15142.
23. Cua DJ. Sherlock J. Chen Y. et al. lnterleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744-748.
24. Park H, Li Z. Yang XO. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-1141.
25. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132.
26. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
27. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441: 231-234.
28. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of lL-17-producing T cells. Immunity. 2006;24:179-189.
29. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-1133.
30. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942-949.
31. Wilson NJ, Boniface K, Chan JR. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-957.
32. Yang L, Anderson DE. Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. Prepublished May 11, 2008 as DOI 10.1038/nature07021.
33. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008;9:641-649.
34. Volpe E, Servant N, Zollinger R, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol. 2008;9:650-657.
35. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448:484-487.
36. Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448:480-483.
37. Zhou L, Ivanov ll, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and lL-23 pathways. Nat Immunol. 2007;8:967-974.
38. Sakaguchi S, Sakaguchi N, Asano M, ltoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing lL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995:155:1151-1164.
39. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001:27: 68-73.
40. Patel DD. Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. J Clin Invest. 2001; 107:155-157.
41. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27:18-20.
42. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330-336.
43. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
44. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875-1886.
45. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-lgE syndrome. Nature. 2008;452:773-776.
46. Holland SM, DeLeo FR. Elloumi HZ, et al. STAT3 mutations in the hyper-lgE syndrome. N Engl J Med. 2007;357:1608-1619.
47. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-lgE syndrome. Nature. 2007; 448:1058-1062.
48. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516-518.
49. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest. 1991;87:949-954.
50. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med. 1997;186: 1233-1240.
51. Darrah PA, Patel DT, De Luca PM, et al. Multi-functional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13:843-850.
52. Williams MA, TyznikAJ, Sevan MJ. lnterleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 2006;441:890-893.
53. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993;362:245-248.
54. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989;245:308-310.
55. Longphre M, Li D, Gallup M, et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest. 1999;104:1375-1382.
56. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081-2095.
57. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
58. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-456.
59. Urban JF Jr, Noben-Trauth N, Donaldson DD, et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 1998;8:255-264.
60. Zaiss DM, Yang L, Shah PR, Kobie JJ, Urban JF, Mosmann TR. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science. 2006; 314:1746.
61. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15:985-995.
62. Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007;204:1509-1517.
63. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203:1105-1116.
64. Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811-821.
65. Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine. IL-17F, and implications for receptor binding. EMBO J. 2001;20:5332-5341.
66. Leonard WJ, Spolski R. lnterleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005;5:688-698.
67. Zheng Y Danilenko DM, Valdez P, et al. lnterleukin-22, aT(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648-651.
68. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453:106-109.
69. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007;27:647-659.
70. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gramnegative bacterial pneumonia. Nat Med. 2008; 14:275-281.
71. Zheng Y, Valdez PA, Danilenko DM, et al. lnterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282-289.
72. Joffre O, SantolariaT, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatoryT lymphocytes. Nat Med. 2008;14:88-92.
73. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25:455-471.
74. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity. 2007;26:579-591.
75. Asseman C, Read S, Powrie F. ColitogenicTh1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J Immunol. 2003;171:971-978.
76. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995-1004.
77. Rubtsov YP, Rasmussen JP, Chi EY, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28:546-558.
78. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.
79. Collison LW. Workman CJ. Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450:566-569.
80. Stumhofer JS. Silver JS. Laurence A. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol. 2007; 8:1363-1371.
81. Gavin MA. Rasmussen JP, Fontenot JD, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445:771-775.
82. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997;185:817-824.
83. Afkarian M, Sedy JR. Yang J, et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol. 2002;3:549-557.
84. Usui T, Preiss JC, Kanno Y, et al. T-bet regulates Th1 responses through essential effects on GATA-3 function ratherthan on IFNG gene acetylation and transcription. J Exp Med. 2006;203: 755-766.
85. Kano S. Sato K. Morishita Y, et al. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and THl versus TH-17 differentiation of CD4+ T cells. Nat Immunol. 2008;9:34-41.
86. Robinson D, Shibuya K, MuiA, et al. IGlFdoes not drive Th1 development but synergizes with lL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity. 1997;7: 571-581.
87. Yang J, Zhu H. Murphy TL, Ouyang W. Murphy KM. IL-18-stimulated GADD45 beta required in cytokine-induced. but not TCR-induced. IFN-gamma production. Nat Immunol. 2001;2:157-164.
88. Sallusto F, Lenig D, Mackay CR. Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883.
89. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med. 1998;187:129-134.
90. Loetscher P. Uguccioni M, Bordoli L, et al. CCR5 is characteristic of Th1 lymphocytes. Nature. 1998;391:344-345.
91. Hwang ES, White IA, Ho IC. An IL-4-independent and CD25-mediated function of c-maf in promoting the production of Th2 cytokines. Proc Natl Acad Sci U S A. 2002;99:13026-13030.
92. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-490.
93. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;277:2005-2007.
94. D'Ambrosio D, lellem A, Bonecchi R, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol. 1998;161:5111-5115.
95. Nagata K. Tanaka K, Ogawa K, et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol. 1999;162:1278-1286.
96. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med. 2006;203:1685-1691.
97. Acosta-Rodriguez EV. Rivino L. Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639-646.
98. Liu W. Putnam AL Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203:1701-1711.
99. Lehmann J, Huehn J, de la Rosa M, et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25-regulatoryT cells. Proc Natl Acad Sci U S A. 2002;99:13031-13036.
100. Finotto S. Neurath MF. Glickman JN, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 2002;295:336-338.
101. Pearce EL, Mullen AC, Martins GA, et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science. 2003;302: 1041-1043.
102. Suto A, WursterAL, Reiner SL, GrusbyMJ. lL-21 inhibits lFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J Immunol. 2006;177:3721-3727.
103. Kaplan MH, Sun YL, HoeyT, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 1996;382:174-177.
104. Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996;382:171-174.
105. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence II4 in T helper type 1 cells. Nat Immunol. 2007;8:145-153.
106. Naoe Y, Setoguchi R, Akiyama K, et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the II4 silencer. J Exp Med. 2007;204:1749-1755.
107. Mullen AC, Hutchins AS, High FA, et al. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol. 2002;3:652-658.
108. Kaplan MH, Schindler U, Smiley ST. Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 1996;4:313-319.
109. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and lgE class switching in mice with disrupted State gene. Nature. 1996;380:630-633.
110. Takeda K, Tanaka T, Shi W, et al. Essential role of State in IL-4 signalling. Nature. 1996;380:627-630.
111. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Paul WE, Sher A. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J Immunol. 2000;164:3047-3055.
112. Min B, Prout M, Hu-Li J, et al. Basophils produce IL-4 and accumulate in tissues after infection with aTh2-inducing parasite. J Exp Med. 2004;200: 507-517.
113. Finkelman FD, Morris SC, Orekhova T, et al. Stat6 regulation of in vivo IL-4 responses. J Immunol. 2000;164:2303-2310.
114. Kurata H, Lee HJ, O'Garra A, Arai N. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity. 1999; 11:677-688.
115. Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE. State is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol. 2001;166:7276-7281.
116. Ouyang W, Ranganath SH, Weindel K, etal. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998;9:745-755.
117. Zhu J, Min B, Hu-Li J, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5:1157-1165.
118. Pai SYTruitt ML Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A. 2004;101:1993-1998.
119. Lin JX, Leonard WJ. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene. 2000;19:2566-2576.
120. Zhu J, Cote-Sierra J, Guo L, Paul WE. Stat5 activation plays a critical role in Th2 differentiation. Immunity. 2003;19:739-748.
121. Kim Jl, Ho lC, Grusby MJ, Glimcher LH. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity. 1999;10:745-751.
122. Lohoff M, Mittrucker HW, Prechtl S, et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A. 2002;99:11808-11812.
123. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med. 2002; 195:1003-1012.
124. Zhu J, Guo L, Min B, et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity. 2002;16:733-744.
125. Zhu J, Jankovic D, Grinberg A, Guo L, Paul WE. Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc Natl Acad Sci U S A. 2006; 103:18214-18219.
126. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29-39.
127. Harris TJ, Grosso JF, Yen HR, et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313-4317.
128. Mathur AN, Chang HC, Zisoulis DG.et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol. 2007;178:4901-4907.
129. Laurence A, Tato CM, Davidson TS, et al. lnterleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371-381.
130. Brüstle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol. 2007; 8:958-966.
131. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007;8:277-284.
132. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007;445:766-770.
133. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. Cutting Edge: IL-2 is essential forTGF-betamediated induction of Foxp3+ T regulatory cells. J Immunol. 2007;178:4022-4026.
134. Yao Z, Kanno Y, Kerenyi M, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 2007;109:4368-4375.
135. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2007;178: 280-290.
136. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7:179-190.
137. Murphy KM, Reiner SL. The lineage decisions of helperT cells. Nat Rev Immunol. 2002;2:933-944.
138. Yamane H, Zhu J, Paul WE. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J Exp Med. 2005;202:793-804.
139. Ouyang W. Lohning M. Gao Z, et al. Stateindependent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity. 2000;12:27-37.
140. Zhu J. Yamane H. Cote-Sierra J. Guo L. Paul WE. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 2006;16:3-10.
141. Amsen D. Blander JM. Lee GR, Tanigaki K. Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigenpresenting cells. Cell. 2004;117:515-526.
142. Liu Y. Zhang P. Li J. Kulkarni AB. Perruche S. Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatoryT cells. Nat Immunol. 2008;9:632-640.
143. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med. 2005;201:1061-1067.
144. Tone Y Furuuchi K, Kojima Y, Tykocinski ML, Greene Ml. Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9:194-202.
145. Burchill MA, Yang J, Vang KB, et al. LinkedTcell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity. 2008;28:112-121.
146. Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol. 2000;165:4773-4777.
147. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science. 2005;307:430-433.
148. Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing ROR gammat function. Nature. 2008;453:236-240.
149. Usui T, Nishikomori R. Kitani A, Strober W. GATA-3 suppresses Th1 development by down-regulation of Stat4 and not through effects on lL-12Rbeta2 chain or T-bet. Immunity. 2003;18:415-428.
150. Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT Cell. 2006;126:375-387.
151. Ono M, Yaguchi H, Ohkura N, et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 2007;446:685-689.
152. Spilianakis CG. Lalioti MD, Town T Lee GR, Flavell RA. Interchromosomal associations between alternatively expressed loci. Nature. 2005; 435:637-645.
153. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823-837.
154. Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA. Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity. 2004;21:865-876.
155. Lee GR, Spilianakis CG, Flavell RA. Hypersensitive site 7 of the TH2 locus control region is essential for expressing TH2 cytokine genes and for long-range intrachromosomal interactions. Nat Immunol. 2005;6:42-48.
156. Kim ST, Fields PE, Flavell RA. Demethylation of a specific hypersensitive site in the Th2 locus control region. Proc Natl Acad Sci 3U S A. 2007;104: 17052-17057.
157. Loots GG, Locksley RM, Blankespoor CM, et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science. 2000;288:136-140.
158. Mohrs M, Blankespoor CM, Wang ZE, et al. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat Immunol. 2001;2:842-847.
159. Henkel G, Weiss DL, McCoy R, DelougheryT, Tara D, Brown MA. A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer. J Immunol. 1992;149:3239-3246.
160. Solymar DC, Agarwal S, Bassing CH, Alt FW, Rao A. A3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity. 2002;17:41-50.
161. Guo L, Hu-LiJ, Paul WE. Probabilistic regulation in TH2 cells accounts for monoallelic expression of IL-4 and IL-13. Immunity. 2005;23:89-99.
162. ChatilaTA, Blaeser F, Ho N, et al. JM2, encoding afork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest. 2000;106:R75-81.
163. CaudyAA, Reddy ST, ChatilaT, Atkinson JP. Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective lL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol. 2007;119:482-487.
164. Van Esch H, Groenen P, Nesbit MA, et al. GATA3 haplo-insufficiency causes human H D R syndrome. Nature. 2000;406:419-422.
165. Skapenko A, Leipe J, Niesner U, et al. GATA-3 in human T cell helper type 2 development. J Exp Med. 2004;199:423-428.
166. Pykalainen M, Kinos R, Valkonen S, et al. Association analysis of common variants of STAT6, GATA3. and STAT4 to asthma and high serum lgE phenotypes. J Allergy Clin Immunol. 2005; 115:80-87.
167. Raby BA, Hwang ES, Van Steen K, et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med. 2006;173:64-70.
168. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med. 1997; 337:1720-1725.
169. Risma KA, Wang N, Andrews RP, et al. V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptorfunction. J Immunol. 2002;169:1604-1610.
170. Mitsuyasu H, Izuhara K, Mao XQ, et al. lle50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet. 1998;19:119-120.
171. Mitsuyasu H, Yanagihara Y, Mao XQ, et al. Cutting edge: dominant effect of lle50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol. 1999;162:1227-1231.
172. Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med. 2003;197:527-535.
173. de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998;280:1435-1438.
174. Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002;70:336-348.
175. Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest. 2000;105:1429-1436.
176. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 1996;335:1956-1961.
177. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941-1949.
178. Duerr RH, Taylor KD, Brant SR, et al. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314:1461-1463.
179. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25: 745-755.